PharmaTher Holdings Ltd.
PharmaTher Holdings Ltd.
CSE Index:
CSE CompositeCurrency:
CAD PharmaTher Holdings Ltd. develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting novel delivery methods to enhance patient outcomes. The Company’s lead product is KETARX™ (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. Learn more at PharmaTher.com.
PharmaTher Holdings Ltd. (PHRM)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
1-888-846-3171Email
info@pharmather.comWebsite
https://www.pharmather.comListing date
Friday, October 9, 2020Transfer Agent
Computershare Investor Services Inc.SEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
1-888-846-3171Email
info@pharmather.comWebsite
https://www.pharmather.comListing date
Friday, October 9, 2020Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
88169065Reserved for Issuance:
5699000Company Officers
Fabio Chianelli, Chief Executive Officer
Carmelo Marrelli, Chief Financial Officer
Bulletins
13/04/2021
2021-0416 – Name Change – Newscope Capital Corporation (PHRM)
le 13 avril/April 2021
Newscope Capital Corporation has announced a name change to PharmaTher Holdings Ltd.
The shares will begin trading under the new name on April 15, 2021.
The symbol will remain the same.
Disclosure documents are available at www.thecse.com
